These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8736524)

  • 1. Radiation protection issues.
    O'Doherty MJ; Barrington SF; Kettle AG; Mountford PJ; Coakley AJ
    Nucl Med Commun; 1996 May; 17(5):443-6. PubMed ID: 8736524
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation protection issues associated with nuclear medicine out-patients.
    Hilditch TE; Elliott AT
    Nucl Med Commun; 1996 May; 17(5):441-2, 445-6. PubMed ID: 8736523
    [No Abstract]   [Full Text] [Related]  

  • 3. NRC absorbed dose reconstruction for family member of 131I therapy patient: case study and commentary.
    Marcus CS; Siegel JA
    J Nucl Med; 2004 Apr; 45(4):13N-6N, 37N. PubMed ID: 15073236
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiation protection issues associated with nuclear medicine out-patients.
    Thomson WH; Harding LK
    Nucl Med Commun; 1995 Nov; 16(11):879-92. PubMed ID: 8587752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release criteria from hospitals of 131I thyrotoxicosis therapy patients in developing countries--case study.
    Muhammad W; Faaruq S; Matiullah ; Hussain A; Khan AA
    Radiat Prot Dosimetry; 2006; 121(2):136-9. PubMed ID: 16464838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I therapy: inpatient or outpatient?
    de Klerk JM
    J Nucl Med; 2000 Nov; 41(11):1876-8. PubMed ID: 11079498
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Knowingly and willingly in the support and comfort of a patient'.
    Harding LK; Thomson WH
    Nucl Med Commun; 1995 Nov; 16(11):877-8. PubMed ID: 8587751
    [No Abstract]   [Full Text] [Related]  

  • 8. Definitive improvement in the approach to the treated patient as a radioactive source.
    Lubin E
    J Nucl Med; 2002 Mar; 43(3):364-5. PubMed ID: 11884496
    [No Abstract]   [Full Text] [Related]  

  • 9. Online regulatory guide errors.
    Dawry FP
    J Nucl Med; 2002 Feb; 43(2):284. PubMed ID: 11858234
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years?
    Shapiro B
    J Nucl Med; 1993 Oct; 34(10):1638-41. PubMed ID: 8410274
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy.
    Marriott CJ; Webber CE; Gulenchyn KY
    Radiat Prot Dosimetry; 2007; 123(1):62-7. PubMed ID: 16825250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
    Cosset JM; Pinillos-Ashton L; Mettler F;
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S50-5. PubMed ID: 15679247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishing a threshold for 131I bioassay in nuclear medicine personnel.
    Liang Y; Chu RY; Galbraith WK; Macdurmon GW; Sonnad JR
    Health Phys; 2008 Nov; 95(5 Suppl):S175-9. PubMed ID: 18849711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new proposal for monitoring patients in nuclear medicine.
    Willegaignon J; Guimarães MI; Sapienza MT; Stabin MG; Malvestiti LF; Marone M; Sordi GM
    Health Phys; 2006 Dec; 91(6):624-9. PubMed ID: 17099406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Organization of the nuclear medicine department].
    Martinenghi C
    Minerva Med; 1970 Oct; 61(80):4430-46. PubMed ID: 5481345
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
    Coover LR; Silberstein EB; Kuhn PJ; Graves MW
    J Nucl Med; 2000 Nov; 41(11):1868-75. PubMed ID: 11079497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Considerations on the general principles that must be known by those planning a hospital department of nuclear medicine].
    Lelli A
    Minerva Med; 1967 May; 58(37):1754-61. PubMed ID: 6026754
    [No Abstract]   [Full Text] [Related]  

  • 18. New tool for nuclear medicine patient release calculations.
    Stabin M; Marcus C; Siegel J
    J Nucl Med; 2009 Jun; 50(6):14N. PubMed ID: 19470846
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
    Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
    Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid reports: insight into radioiodine ablation and new guidelines for nodule management.
    J Nucl Med; 2006 Mar; 47(3):15N, 26N. PubMed ID: 16594104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.